Valeo Pharma Names Chief Development Officer; Up Nearly 22%

Valeo Pharma (VPH.TO), a Canadian pharmaceutical company, on Tuesday soared nearly 22% on last look after reporting the appointment of Al Moghaddam to the newly created role of chief development offic

MT NewswiresJun 18 09:56 ET

Valeo Pharma Adds Chief Development Officer to Drive Growth Initiatives | TSX:VPH, OTCQB:VPHIF

Proactive InvestorsJun 18 05:11 ET

Valeo Pharma Fiscal Q2 Loss Widens 21% as Expenses Increase; Revenue Up 4%

Valeo Pharma (VPH.TO), which surged nearly 41% in Canada yesterday, said on Thursday that its fiscal second-quarter loss widened 21% mainly due to an increase in financial, sales, and marketing expens

MT NewswiresJun 14 07:03 ET

Valeo Pharma Sees Record 2Q Revenue Boosted by Respiratory Products and Core Brand Growth | TSX:VPH, OTCQB:VPHIF

Proactive InvestorsJun 14 04:18 ET

Toronto Stocks Retreat; ADF Group Shares Fall on C$47.9M Buyback From Certain Board Members

Toronto stocks were firmly lower Thursday at midday as most sectors were trending lower. Energy stocks were the most in decline, followed by communications and process industries.

WSJJun 13 16:10 ET · Markets

Valeo Pharma Restructures Field Operations to Save Over $5m Annually | TSX:VPH, OTCQB:VPHIF

Proactive InvestorsJun 13 04:21 ET